{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:36:09Z","timestamp":1790764569556,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10,18]]},"DOI":"10.1097\/qad.0b013e328310e04f","type":"journal-article","created":{"date-parts":[[2008,10,2]],"date-time":"2008-10-02T03:09:47Z","timestamp":1222916987000},"page":"2187-2198","source":"Crossref","is-referenced-by-count":28,"title":["Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study"],"prefix":"10.1097","volume":"22","author":[{"given":"Alessandro","family":"Cozzi-Lepri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Mocroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Lazzarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Wiercinska-Drapalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens D","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210130","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/01.aids.0000131310.52526.c7","article-title":"The prevalence of antiretroviral drug resistance in the United States","volume":"18","author":"Richman","year":"2004","journal-title":"AIDS"},{"key":"R2-16-20210130","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.279.24.1977","article-title":"Public health implications of antiretroviral therapy and HIV drug resistance","volume":"279","author":"Wainberg","year":"1998","journal-title":"JAMA"},{"key":"R3-16-20210130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7824947","article-title":"HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy","volume":"267","author":"Coffin","year":"1995","journal-title":"Science"},{"key":"R4-16-20210130","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.279.24.2000","article-title":"Drug-resistant HIV-1: the virus strikes back","volume":"279","author":"Mayers","year":"1998","journal-title":"JAMA"},{"key":"R5-16-20210130","first-page":"36","article-title":"The impact of antiretroviral therapy on AIDS and survival","volume":"11","author":"Lundgren","year":"2006","journal-title":"J HIV Ther"},{"key":"R6-16-20210130","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/01.aids.0000189864.90053.22","article-title":"Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984\u20132004","volume":"19","author":"Schneider","year":"2005","journal-title":"AIDS"},{"key":"R7-16-20210130","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/01.aids.0000174455.01369.ad","article-title":"Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients","volume":"19","author":"Zaccarelli","year":"2005","journal-title":"AIDS"},{"key":"R8-16-20210130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/aid.2007.0070","article-title":"Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure","volume":"24","author":"Di Giambenedetto","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R9-16-20210130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1468-1293.2004.00244.x","article-title":"An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy","volume":"5","author":"Ormaasen","year":"2004","journal-title":"HIV Med"},{"issue":"Suppl 1","key":"R10-16-20210130","first-page":"S68","article-title":"Extensive HIV-1 antiretroviral drug class resistance is associated with inferior virological and clinical outcomes [abstract 59]","volume":"12","author":"Napravnick","year":"2007","journal-title":"Antivir Ther"},{"key":"R11-16-20210130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/135965350701200606","article-title":"Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure","volume":"12","author":"Lohse","year":"2007","journal-title":"Antivir Ther"},{"key":"R12-16-20210130","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1097\/01.aids.0000131339.68666.1a","article-title":"Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing","volume":"18","author":"Lucas","year":"2004","journal-title":"AIDS"},{"key":"R13-16-20210130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jac\/dki042","article-title":"Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven","volume":"55","author":"Lucas","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R14-16-20210130","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1371\/journal.pmed.0030356","article-title":"Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.1","volume":"3","author":"Hogg","year":"2006","journal-title":"PLoS Med"},{"key":"R15-16-20210130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1310\/hct0806-357","article-title":"The incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-na\u00efve participants started on three different antiretroviral therapy strategies","volume":"8","author":"Kozal","year":"2007","journal-title":"HIV Clin Trials"},{"key":"R16-16-20210130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/427192","article-title":"Predictors of HIV drug-resistance mutations in a large antiretroviral-na\u00efve cohort initiating triple antiretroviral therapy","volume":"191","author":"Harrigan","year":"2005","journal-title":"J Infect Dis"},{"key":"R17-16-20210130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.aids.0000162337.58557.3d","article-title":"Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice","volume":"19","author":"Phillips","year":"2005","journal-title":"AIDS"},{"key":"R18-16-20210130","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/135965350601100503","article-title":"Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome. Collaborative Group for Clinical Use of HIV Genotype Resistance Test","volume":"11","author":"Tozzi","year":"2006","journal-title":"Antivir Ther"},{"key":"R19-16-20210130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0b013e32805e8764","article-title":"Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients","volume":"21","author":"Napravnik","year":"2007","journal-title":"AIDS"},{"key":"R20-16-20210130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-1293.2006.00424.x","article-title":"British HIV Association (BHIVA) Guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)","volume":"7","author":"Gazzard","year":"2006","journal-title":"HIV Med"},{"key":"R21-16-20210130","first-page":"105","article-title":"Updated DHHS treatment guidelines","volume":"18","author":"Sax","year":"2006","journal-title":"AIDS Clin Care"},{"key":"R22-16-20210130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1086\/422007","article-title":"Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy","volume":"190","author":"Recsky","year":"2004","journal-title":"J Infect Dis"},{"key":"R23-16-20210130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","article-title":"Decline in the AIDS and death rates in the EuroSIDA study: an observational study","volume":"362","author":"Mocroft","year":"2003","journal-title":"Lancet"},{"key":"R24-16-20210130","first-page":"125","article-title":"Update of the drug resistance mutations in HIV-1: fall 2006","volume":"14","author":"Johnson","year":"2006","journal-title":"Top HIV Med"},{"key":"R25-16-20210130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jama.283.2.250","article-title":"Resistance, fitness, adherence, and potency: mapping the paths to virologic failure","volume":"283","author":"Markowitz","year":"2000","journal-title":"JAMA"},{"key":"R26-16-20210130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00001432-200102000-00005","article-title":"Implications of antiretroviral resistance on viral fitness","volume":"14","author":"Nijhuis","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"R27-16-20210130","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1128\/JVI.77.10.6041-6049.2003","article-title":"Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity","volume":"77","author":"Price","year":"2003","journal-title":"J Virol"},{"key":"R28-16-20210130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/380098","article-title":"Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1","volume":"189","author":"Deeks","year":"2004","journal-title":"J Infect Dis"},{"key":"R29-16-20210130","doi-asserted-by":"crossref","first-page":"14169","DOI":"10.1128\/JVI.79.22.14169-14178.2005","article-title":"Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment","volume":"79","author":"Emu","year":"2005","journal-title":"J Virol"},{"key":"R30-16-20210130","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/89090","article-title":"Impaired replication of protease inhibitor-resistant HIV-1 in human thymus","volume":"7","author":"Stoddart","year":"2001","journal-title":"Nat Med"},{"key":"R31-16-20210130","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1097\/00002030-199912030-00006","article-title":"Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy","volume":"13","author":"Nijhuis","year":"1999","journal-title":"AIDS"},{"key":"R32-16-20210130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/QAD.0b013e3280141fdf","article-title":"Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen","volume":"21","author":"Cozzi-Lepri","year":"2007","journal-title":"AIDS"},{"key":"R33-16-20210130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","article-title":"Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study","volume":"366","author":"Sterne","year":"2005","journal-title":"Lancet"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200810180-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:05:06Z","timestamp":1786035906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200810180-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,18]]},"references-count":33,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328310e04f","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10,18]]}}}